Jae‐Seok Roe

4.5k citations
45 papers · 2.1k indexed · h-index 22
Topics
Protein Degradation and Inhibitors (14 papers)Multiple Myeloma Research and Treatments (8 papers)Histone Deacetylase Inhibitors Research (8 papers)

In The Last Decade

Jae‐Seok Roe

44 papers receiving 2.0k citations

Peers

Jae‐Seok Roe
Comparison fields: 5 of 91
  • Molecular Biology 1.6k
  • Cancer Research 479
  • Oncology 376
  • Hematology 275
  • Immunology 249
Replace Nilgun Tasdemir with:
Nilgun Tasdemir United States
Jeffrey A. Magee United States
Wen-Mei Yu United States
Peter Staller Germany
Rachel A. Altura United States
Katti Jessen United States
Linsey B. Reavie United States
Stephanie Z. Xie United States
Teruyuki Muraguchi Japan
Cornelia Rudolph Germany
Jae‐Seok Roe relative to Nilgun Tasdemir United States Nilgun Tasdemir's profile →
Citations per field
00.5×1.5×2.4×
Nilgun Tasdemir · 1×
Citations per year

Countries citing papers authored by Jae‐Seok Roe

Since Specialization
Citations

This map shows the geographic impact of Jae‐Seok Roe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jae‐Seok Roe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jae‐Seok Roe more than expected).

Fields of papers citing papers by Jae‐Seok Roe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jae‐Seok Roe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jae‐Seok Roe. The network helps show where Jae‐Seok Roe may publish in the future.

Co-authorship network of co-authors of Jae‐Seok Roe

This figure shows the co-authorship network connecting the top 25 collaborators of Jae‐Seok Roe. A scholar is included among the top collaborators of Jae‐Seok Roe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jae‐Seok Roe. Jae‐Seok Roe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 8
3 16
4 0
5 5
6 9
7 30
8 43
9 25
10 37
11 25
12 278
13 18
14 120
15 109
16 21
17 17
18 13
19 21
20 43

About Jae‐Seok Roe

Jae‐Seok Roe is a scholar working on Hematology, Cancer Research and Molecular Biology, having authored 45 papers that have together received 2.1k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (14 papers), Multiple Myeloma Research and Treatments (8 papers) and Histone Deacetylase Inhibitors Research (8 papers). The work is most often cited by research in Cancer Research (479 citations), Hematology (275 citations) and Molecular Biology (1.6k citations). Jae‐Seok Roe has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Christopher R. Vakoc, Hong‐Duk Youn, Eun‐Jung Cho, Darryl Pappin, Keith Rivera, Junwei Shi, Hwa-Ryeon Kim, Hyungsoo Kim, Anja Hohmann and Chun‐Hao Huang. Their work appears in journals such as Nucleic Acids Research, The Journal of Experimental Medicine and Genes & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026